Moneycontrol PRO

business

US FDA blow to Aurobindo Pharma; issues 9 observations to unit 4

Watch accompanying video of CNBC-TV18's Ekta Batra who accessed form 483 issued to Aurobindo Pharma's unit 4. US FDA has issued 9 observations to Aurobindo unit 4.

first published: Mar 3, 2018 05:13 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347